Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Comparison between standard heparin and tinzaparin for haemodialysis catheter lock.

Malo J, Jolicoeur C, Theriault F, Lachaine J, Senecal L.

ASAIO J. 2010 Jan-Feb;56(1):42-7. doi: 10.1097/MAT.0b013e3181c84e61.

PMID:
20051836
2.

Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.

Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P.

Am J Kidney Dis. 2014 Mar;63(3):479-90. doi: 10.1053/j.ajkd.2013.08.016. Epub 2013 Oct 11. Review.

PMID:
24125729
3.

Tinzaparin sodium: a low-molecular-weight heparin.

Neely JL, Carlson SS, Lenhart SE.

Am J Health Syst Pharm. 2002 Aug 1;59(15):1426-36. Review.

PMID:
12166042
4.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006649. doi: 10.1002/14651858.CD006649.pub5. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD006649.

PMID:
21678360
5.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006649. doi: 10.1002/14651858.CD006649.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD006649.

PMID:
21491395
6.

The low molecular weight heparin, tinzaparin, in thrombosis and beyond.

Mousa SA.

Cardiovasc Drug Rev. 2002 Fall;20(3):199-216. Review.

PMID:
12397367
7.

Alteplase for the treatment of catheter occlusion in pediatric patients.

Anderson DM, Pesaturo KA, Casavant J, Ramsey EZ.

Ann Pharmacother. 2013 Mar;47(3):405-9. doi: 10.1345/aph.1Q483. Epub 2013 Mar 5. Review.

PMID:
23463740
8.

Pros and cons of catheter lock solutions.

Niyyar VD, Lok CE.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):669-74. doi: 10.1097/MNH.0b013e328365ba53. Review.

PMID:
24100219
9.

Development of tinzaparin: a heparinase-digested low-molecular-weight heparin.

Hedner U.

Semin Thromb Hemost. 2000;26 Suppl 1:23-9. Review.

PMID:
11011803
10.

The safety of heparins in end-stage renal disease.

Sonawane S, Kasbekar N, Berns JS.

Semin Dial. 2006 Jul-Aug;19(4):305-10. Review.

PMID:
16893408
11.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Rohilla S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann HJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006649. doi: 10.1002/14651858.CD006649.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006649.

PMID:
18254108

Supplemental Content

Support Center